219 related articles for article (PubMed ID: 30688717)
21. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis.
Mukamal KJ; Ghimire S; Pandey R; Fiarman GS; Gautam S
Ann Epidemiol; 2012 Oct; 22(10):747-50. PubMed ID: 22867943
[TBL] [Abstract][Full Text] [Related]
22. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
23. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
Locatelli F; Del Vecchio L; Andrulli S; Colzani S
Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
[TBL] [Abstract][Full Text] [Related]
24. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
25. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
Burke TA; Sturkenboom MC; Lu SE; Wentworth CE; Lin Y; Rhoads GG
J Hypertens; 2006 Jun; 24(6):1193-200. PubMed ID: 16685222
[TBL] [Abstract][Full Text] [Related]
27. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
28. Safety of the newer antihypertensive agents in children.
Blowey DL
Expert Opin Drug Saf; 2002 May; 1(1):39-43. PubMed ID: 12904158
[TBL] [Abstract][Full Text] [Related]
29. Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study.
Nielsen SK; Lamberts M; Nouhravesh N; Jensen MH; Strange JE; Gislason G; Mcgettigan P; Holt A
Int J Cardiol; 2024 Aug; 408():132137. PubMed ID: 38705205
[TBL] [Abstract][Full Text] [Related]
30. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis.
Palmas W; Ma S; Psaty B; Goff DC; Darwin C; Barr RG
Am J Hypertens; 2007 Mar; 20(3):233-41. PubMed ID: 17324732
[TBL] [Abstract][Full Text] [Related]
32. Antihypertensive drugs and the risk of fall injuries: a systematic review and meta-analysis.
Zang G
J Int Med Res; 2013 Oct; 41(5):1408-17. PubMed ID: 24051019
[TBL] [Abstract][Full Text] [Related]
33. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
[TBL] [Abstract][Full Text] [Related]
35. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.
Padwal R; Mamdani M; Alter DA; Hux JE; Rothwell DM; Tu K; Laupacis A
Diabetes Care; 2004 Oct; 27(10):2458-63. PubMed ID: 15451916
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
38. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
